Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06333990 · ClinicalTrials.gov registry record · Phase 3
Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)
A Phase 3 study of Mild Traumatic Brain Injury, sponsored by Foundation for Advancing Veterans' Health Research.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 146
- Enrollment target
- 2
- Study locations
NCT06333990 is a Phase 3 study of Mild Traumatic Brain Injury that is actively recruiting participants, run by Foundation for Advancing Veterans' Health Research. The registered enrollment target is 146 participants, below the 217-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (33% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06333990, a Phase 3 study of Mild Traumatic Brain Injury, is actively recruiting participants, sponsored by Foundation for Advancing Veterans' Health Research.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 146 participants
- Enrollment target
- 2
- Study locations
Study Summary
A two site, 2-arm, Phase III randomized pragmatic clinical trial evaluating the effectiveness of quetiapine monotherapy in comparison to Treatment As Usual (TAU) medication management for symptoms experienced by veterans receiving rehabilitation therapy for mild traumatic brain injury (mTBI) and comorbid symptoms of posttraumatic stress disorder (PTSD).
Conditions Studied
Interventions
- DRUG TAU
- DRUG Quetiapine Fumarate
Study Locations (2)
New Mexico
- New Mexico VA Healthcare System - Albuquerque
Texas
- South Texas Veterans Healthcare System - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2024-07-09 |
| Est. Completion | 2028-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06333990
The ClinicalTrials.gov registry entry for NCT06333990 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 217-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (33% lower). The listed sponsor is Foundation for Advancing Veterans' Health Research, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 2 interventions - of which TAU is the first listed.
NCT06333990 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New Mexico, Texas.
Frequently Asked Questions
What is clinical trial NCT06333990 about?
NCT06333990 is a clinical study titled "Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)". A two site, 2-arm, Phase III randomized pragmatic clinical trial evaluating the effectiveness of quetiapine monotherapy in comparison to Treatment As Usual (TAU) medication management for symptoms experienced by veterans receiving rehabilitation therapy for mild traumatic brain injury (mTBI) and com...
What is the current status of trial NCT06333990?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 146 participants. The study started on 2024-07-09. Estimated completion is 2028-06.
What conditions does trial NCT06333990 study?
This clinical trial studies the following conditions: Mild Traumatic Brain Injury.
What interventions are being tested in trial NCT06333990?
The interventions under investigation include: TAU (DRUG), Quetiapine Fumarate (DRUG).
Who is sponsoring clinical trial NCT06333990?
This trial is sponsored by Foundation for Advancing Veterans' Health Research, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06333990 being conducted?
This trial has 2 study locations across New Mexico, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
RECRUITING · Phase 3
-
Concussion Recovery and Support Program
RECRUITING · NA
-
Vestibular Rehabilitation App for Adults With Dizziness Related to mTBI
RECRUITING · NA
-
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RECRUITING · Phase 2
-
Risk Stratification in Children With Concussion
RECRUITING
-
Combined Neuromodulation and Cognitive Training for Post-mTBI Depression
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.